|
|
|
Antigenics Inc. (NASDAQ: AGEN) announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing...
I’d happily set aside further discussion of cancer screening, if I could. But the story won’t die. In recent days, experts have suggested that doctors should do fewer pap smears and mammograms. I’ve posted on coverage of the...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the Committee for Medicinal Products for Human Use (CHMP), which is responsible for conducting the initial assessment of medicinal products that have been filed for marketing...
Investigators publish new data in the report 'Radiofrequency ablation for renal tumors: our experience.' In this recent report, researchers in Kyoto, Japan conducted a study "To report our results of percutaneous radiofrequency...
Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. Metastatic renal cell carcinoma (RCC) is highly resistant to chemotherapy but responds modestly to cytokine therapy. The prognosis for long-term survival is poor....
Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is the result of a combined effort. Collaboration of experts from various fields is, therefore, necessary to take cancer-related...
The United States insists that weapons containing depleted uranium (DU) pose no health hazards to exposed populations. This charade persists because an artful propaganda matrix has infiltrated and corrupted certain aspects of...
OBJECTIVE. The objective of this study was to evaluate the effectiveness of CT-guided injection of 5% dextrose in water solution (D5W) into the retroperitoneum to displace organs adjacent to renal cell carcinoma. MATERIALS AND...
Story Created: Nov 19, 2009 at 8:32 PM CST Story Updated: Nov 20, 2009 at 12:06 AM CST CORALVILLE - Faith carries the 30-year-old Coralville woman through her battles with cancer. Doctors told Abbey's family it was...
preliminary opinion was announced in a press release issued last month Antigenics Inc. (NASDAQ: AGEN) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European...
